Cargando…

Current Advances and Future Prospects in Cancer Immunotherapeutics

Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, canc...

Descripción completa

Detalles Bibliográficos
Autores principales: DEDE, Zeynep, TUMER, Kader, KAN, Tugce, YUCEL, Burcu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064104/
https://www.ncbi.nlm.nih.gov/pubmed/36974661
http://dx.doi.org/10.4274/MMJ.galenos.2023.29599
_version_ 1785017838946222080
author DEDE, Zeynep
TUMER, Kader
KAN, Tugce
YUCEL, Burcu
author_facet DEDE, Zeynep
TUMER, Kader
KAN, Tugce
YUCEL, Burcu
author_sort DEDE, Zeynep
collection PubMed
description Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods.
format Online
Article
Text
id pubmed-10064104
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-100641042023-04-01 Current Advances and Future Prospects in Cancer Immunotherapeutics DEDE, Zeynep TUMER, Kader KAN, Tugce YUCEL, Burcu Medeni Med J Review Cancer is a disease that results from the uncontrolled proliferation and growth of cells. Due to early detection methods, there is a decrease in death rates in many types of cancer. However, among the causes of death worldwide, cancer still ranks second after cardiovascular diseases. Therefore, cancer research has focused mainly on developing more effective treatments to reduce deaths from cancer. With a better understanding of the molecular mechanisms in cancer cells, advances in cancer treatment have evolved and changed. The main priority of research is to develop treatment modalities with the highest response rate and less side effects. In this context, immunotherapies have started a new era in cancer treatments. In this review, an overview of the future of next-generation treatment methods is presented by including the most preferred immunotherapy methods. Galenos Publishing 2023-03 2023-03-27 /pmc/articles/PMC10064104/ /pubmed/36974661 http://dx.doi.org/10.4274/MMJ.galenos.2023.29599 Text en © Copyright 2023 by the Istanbul Medeniyet University / Medeniyet Medical Journal published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc/4.0/Licenced by Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
spellingShingle Review
DEDE, Zeynep
TUMER, Kader
KAN, Tugce
YUCEL, Burcu
Current Advances and Future Prospects in Cancer Immunotherapeutics
title Current Advances and Future Prospects in Cancer Immunotherapeutics
title_full Current Advances and Future Prospects in Cancer Immunotherapeutics
title_fullStr Current Advances and Future Prospects in Cancer Immunotherapeutics
title_full_unstemmed Current Advances and Future Prospects in Cancer Immunotherapeutics
title_short Current Advances and Future Prospects in Cancer Immunotherapeutics
title_sort current advances and future prospects in cancer immunotherapeutics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064104/
https://www.ncbi.nlm.nih.gov/pubmed/36974661
http://dx.doi.org/10.4274/MMJ.galenos.2023.29599
work_keys_str_mv AT dedezeynep currentadvancesandfutureprospectsincancerimmunotherapeutics
AT tumerkader currentadvancesandfutureprospectsincancerimmunotherapeutics
AT kantugce currentadvancesandfutureprospectsincancerimmunotherapeutics
AT yucelburcu currentadvancesandfutureprospectsincancerimmunotherapeutics